A woman sits on the couch wrapped up in a yellow and white blanket with a water bottle and medicine containers sitting in front of her.

73914-1800-x-900

Rhinoviruses, the main cause of the common cold, are unique among respiratory viruses.

How the common cold persisted throughout COVID-19 lockdowns

News

An image of Anna Blakney, a bioengineer at the University of British Columbia.

magnus

An image of Magnus Hoffmann, a biochemist at the California Institute of Technology.

salem

A syringe injects a vaccine from a vial bottle. 

66141-1800-x-900-o

An image of Aliasger Salem, a pharmaceutical scientist at the University of Iowa.

junjun

An image of Jinjun Shi, a cancer biologist at Brigham and Women’s Hospital

Pioneering approaches transform vaccine technologies and shape the future of disease prevention.

A new era of vaccine development

Articles

Illustrations of multiple coronavirus structures in red emerge from the mouth of a man.

istock-1209078209-1800x900-1

Three people in white coats inside a lab looking at a plaque assay.  

image-stanelle-bertram-et-al-cell-reports-medicine-2023

Inhibiting an enzyme variant that contributes to severe COVID-19 in men<a href="#_msocom_1" language="JavaScript" name="_msoanchor_1"></a> holds promise for treating SARS-CoV-2 infections.&nbsp;

COVID-19 severity ties to testosterone metabolism

1-0325-cover

March 2025

Stem cells are shown as clear, purple, and blue spheres against a dark blue and black background.

article

Diagram showing how patient-derived somatic cells are reprogrammed into iPSCs using Yamanaka factors and then differentiated into specialized cell types such as neurons, cardiomyocytes, and hepatocytes.

ips-cells-image

BPS Bioscience

Human-relevant, ready-to-use stem cell models are reshaping drug discovery, toxicity testing, and personalized medicine.

Improving translational research with iPSC-derived cells

mike-heaven-phd

Characterizing lipid nanoparticles for RNA therapeutic development

205c4df9-5f8b-4936-b768-3f926ab08bbc

Inotiv

Integrated multiomics and advanced nanoparticle analytics are improving how researchers perform RNA delivery, increasing therapeutic success.

Characterizing<strong id="isPasted">&nbsp;</strong>lipid nanoparticles for RNA therapeutic development

Webinars

A molecular structure of protein is shown as a swirled structure of blue, orange, and pink strands against a black background.

istock-1225652892-1800x900

 A molecular structure of protein is shown as a swirled structure of blue, orange, and pink strands against a black background.

Thermo Fisher Scientific

Advanced techniques, tools, and strategies can help researchers refine their proteomics workflows, improving downstream results.

respiratory virus

How the common cold persisted throughout COVID-19 lockdowns

A new era of vaccine development

COVID-19 severity ties to testosterone metabolism

Subscribe to our eNewsletters

Sponsored

March 2025